nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—ABCB1—kidney cancer	0.153	1	CbGaD
Morphine—UGT1A1—Pazopanib—kidney cancer	0.0778	0.144	CbGbCtD
Morphine—UGT1A1—Erlotinib—kidney cancer	0.0555	0.103	CbGbCtD
Morphine—UGT1A1—Sorafenib—kidney cancer	0.0451	0.0837	CbGbCtD
Morphine—ABCB1—Temsirolimus—kidney cancer	0.0294	0.0544	CbGbCtD
Morphine—CYP2D6—Temsirolimus—kidney cancer	0.0277	0.0513	CbGbCtD
Morphine—CYP3A4—Everolimus—kidney cancer	0.0261	0.0483	CbGbCtD
Morphine—CYP2C8—Pazopanib—kidney cancer	0.0228	0.0422	CbGbCtD
Morphine—CYP3A4—Temsirolimus—kidney cancer	0.0176	0.0326	CbGbCtD
Morphine—CYP2C8—Erlotinib—kidney cancer	0.0163	0.0301	CbGbCtD
Morphine—ABCB1—Pazopanib—kidney cancer	0.0154	0.0286	CbGbCtD
Morphine—CYP2C8—Paclitaxel—kidney cancer	0.0149	0.0276	CbGbCtD
Morphine—CYP2D6—Pazopanib—kidney cancer	0.0145	0.0269	CbGbCtD
Morphine—ABCB1—Dactinomycin—kidney cancer	0.0141	0.0262	CbGbCtD
Morphine—CYP2C8—Sorafenib—kidney cancer	0.0132	0.0245	CbGbCtD
Morphine—ABCB1—Gemcitabine—kidney cancer	0.0112	0.0207	CbGbCtD
Morphine—ABCB1—Erlotinib—kidney cancer	0.011	0.0204	CbGbCtD
Morphine—CYP2D6—Erlotinib—kidney cancer	0.0104	0.0192	CbGbCtD
Morphine—ABCB1—Paclitaxel—kidney cancer	0.0101	0.0187	CbGbCtD
Morphine—CYP3A4—Pazopanib—kidney cancer	0.00925	0.0171	CbGbCtD
Morphine—ABCB1—Sorafenib—kidney cancer	0.00895	0.0166	CbGbCtD
Morphine—ABCB1—Vinblastine—kidney cancer	0.00884	0.0164	CbGbCtD
Morphine—ABCB1—Vincristine—kidney cancer	0.00869	0.0161	CbGbCtD
Morphine—CYP2D6—Sorafenib—kidney cancer	0.00844	0.0156	CbGbCtD
Morphine—CYP2D6—Vinblastine—kidney cancer	0.00833	0.0154	CbGbCtD
Morphine—ABCB1—Sunitinib—kidney cancer	0.00725	0.0134	CbGbCtD
Morphine—CYP3A4—Erlotinib—kidney cancer	0.0066	0.0122	CbGbCtD
Morphine—CYP3A4—Paclitaxel—kidney cancer	0.00604	0.0112	CbGbCtD
Morphine—ABCB1—Doxorubicin—kidney cancer	0.00543	0.0101	CbGbCtD
Morphine—CYP3A4—Sorafenib—kidney cancer	0.00536	0.00994	CbGbCtD
Morphine—CYP3A4—Vinblastine—kidney cancer	0.0053	0.00982	CbGbCtD
Morphine—CYP3A4—Vincristine—kidney cancer	0.00521	0.00965	CbGbCtD
Morphine—CYP2D6—Doxorubicin—kidney cancer	0.00512	0.00949	CbGbCtD
Morphine—UGT1A1—urine—kidney cancer	0.00492	0.178	CbGeAlD
Morphine—CYP3A4—Sunitinib—kidney cancer	0.00435	0.00805	CbGbCtD
Morphine—CYP3A4—Doxorubicin—kidney cancer	0.00325	0.00603	CbGbCtD
Morphine—UGT1A8—renal system—kidney cancer	0.00276	0.1	CbGeAlD
Morphine—UGT1A8—kidney—kidney cancer	0.00267	0.0967	CbGeAlD
Morphine—UGT2B4—cardiac atrium—kidney cancer	0.0023	0.0833	CbGeAlD
Morphine—CYP3A4—urine—kidney cancer	0.00158	0.057	CbGeAlD
Morphine—CYP2D6—urine—kidney cancer	0.00155	0.0561	CbGeAlD
Morphine—UGT2B7—renal system—kidney cancer	0.00142	0.0512	CbGeAlD
Morphine—OPRD1—renal system—kidney cancer	0.00139	0.0502	CbGeAlD
Morphine—UGT2B7—kidney—kidney cancer	0.00137	0.0495	CbGeAlD
Morphine—OPRD1—kidney—kidney cancer	0.00134	0.0486	CbGeAlD
Morphine—UGT1A1—renal system—kidney cancer	0.0012	0.0436	CbGeAlD
Morphine—UGT1A1—kidney—kidney cancer	0.00116	0.0421	CbGeAlD
Morphine—Galantamine—ACHE—kidney cancer	0.000784	0.376	CrCbGaD
Morphine—CYP2C8—renal system—kidney cancer	0.000569	0.0206	CbGeAlD
Morphine—CYP2C8—kidney—kidney cancer	0.00055	0.0199	CbGeAlD
Morphine—Galantamine—BCHE—kidney cancer	0.000461	0.221	CrCbGaD
Morphine—Hydromorphone—PTGS1—kidney cancer	0.00039	0.187	CrCbGaD
Morphine—CYP3A4—renal system—kidney cancer	0.000386	0.014	CbGeAlD
Morphine—CYP2D6—renal system—kidney cancer	0.00038	0.0137	CbGeAlD
Morphine—CYP3A4—kidney—kidney cancer	0.000373	0.0135	CbGeAlD
Morphine—CYP2D6—kidney—kidney cancer	0.000367	0.0133	CbGeAlD
Morphine—ABCB1—nephron tubule—kidney cancer	0.0003	0.0109	CbGeAlD
Morphine—ABCB1—renal system—kidney cancer	0.000273	0.00988	CbGeAlD
Morphine—ABCB1—kidney—kidney cancer	0.000264	0.00955	CbGeAlD
Morphine—Naltrexone—ABCB1—kidney cancer	0.000261	0.125	CrCbGaD
Morphine—ABCB1—cortex of kidney—kidney cancer	0.000257	0.0093	CbGeAlD
Morphine—ABCB1—gonad—kidney cancer	0.000245	0.00886	CbGeAlD
Morphine—Naloxone—ABCB1—kidney cancer	0.000191	0.0914	CrCbGaD
Morphine—Discomfort—Paclitaxel—kidney cancer	8.41e-05	0.000404	CcSEcCtD
Morphine—Fatigue—Gemcitabine—kidney cancer	8.41e-05	0.000404	CcSEcCtD
Morphine—Gastrointestinal pain—Vincristine—kidney cancer	8.41e-05	0.000404	CcSEcCtD
Morphine—Cardiac arrest—Doxorubicin—kidney cancer	8.36e-05	0.000401	CcSEcCtD
Morphine—Dizziness—Sorafenib—kidney cancer	8.35e-05	0.000401	CcSEcCtD
Morphine—Constipation—Gemcitabine—kidney cancer	8.34e-05	0.0004	CcSEcCtD
Morphine—Pain—Gemcitabine—kidney cancer	8.34e-05	0.0004	CcSEcCtD
Morphine—Nausea—Erlotinib—kidney cancer	8.34e-05	0.0004	CcSEcCtD
Morphine—Dry mouth—Paclitaxel—kidney cancer	8.33e-05	0.0004	CcSEcCtD
Morphine—Mood swings—Doxorubicin—kidney cancer	8.32e-05	0.0004	CcSEcCtD
Morphine—Diarrhoea—Sunitinib—kidney cancer	8.32e-05	0.000399	CcSEcCtD
Morphine—Ataxia—Doxorubicin—kidney cancer	8.26e-05	0.000397	CcSEcCtD
Morphine—Mental disorder—Capecitabine—kidney cancer	8.26e-05	0.000397	CcSEcCtD
Morphine—Asthenia—Dactinomycin—kidney cancer	8.25e-05	0.000396	CcSEcCtD
Morphine—Confusional state—Paclitaxel—kidney cancer	8.23e-05	0.000395	CcSEcCtD
Morphine—Erythema—Capecitabine—kidney cancer	8.21e-05	0.000394	CcSEcCtD
Morphine—Malnutrition—Capecitabine—kidney cancer	8.21e-05	0.000394	CcSEcCtD
Morphine—Dehydration—Doxorubicin—kidney cancer	8.17e-05	0.000392	CcSEcCtD
Morphine—Anaphylactic shock—Paclitaxel—kidney cancer	8.16e-05	0.000392	CcSEcCtD
Morphine—Oedema—Paclitaxel—kidney cancer	8.16e-05	0.000392	CcSEcCtD
Morphine—Body temperature increased—Vincristine—kidney cancer	8.13e-05	0.00039	CcSEcCtD
Morphine—Abdominal pain—Vincristine—kidney cancer	8.13e-05	0.00039	CcSEcCtD
Morphine—Liver function test abnormal—Doxorubicin—kidney cancer	8.11e-05	0.000389	CcSEcCtD
Morphine—Infection—Paclitaxel—kidney cancer	8.11e-05	0.000389	CcSEcCtD
Morphine—Flatulence—Capecitabine—kidney cancer	8.09e-05	0.000388	CcSEcCtD
Morphine—Dry skin—Doxorubicin—kidney cancer	8.05e-05	0.000387	CcSEcCtD
Morphine—Dysgeusia—Capecitabine—kidney cancer	8.04e-05	0.000386	CcSEcCtD
Morphine—Dizziness—Sunitinib—kidney cancer	8.04e-05	0.000386	CcSEcCtD
Morphine—Feeling abnormal—Gemcitabine—kidney cancer	8.04e-05	0.000386	CcSEcCtD
Morphine—Shock—Paclitaxel—kidney cancer	8.03e-05	0.000386	CcSEcCtD
Morphine—Vomiting—Sorafenib—kidney cancer	8.03e-05	0.000386	CcSEcCtD
Morphine—Abdominal pain upper—Doxorubicin—kidney cancer	8.03e-05	0.000385	CcSEcCtD
Morphine—Orthostatic hypotension—Doxorubicin—kidney cancer	8.03e-05	0.000385	CcSEcCtD
Morphine—Nervous system disorder—Paclitaxel—kidney cancer	8.01e-05	0.000384	CcSEcCtD
Morphine—Hypokalaemia—Doxorubicin—kidney cancer	8e-05	0.000384	CcSEcCtD
Morphine—Thrombocytopenia—Paclitaxel—kidney cancer	7.99e-05	0.000384	CcSEcCtD
Morphine—Tachycardia—Paclitaxel—kidney cancer	7.97e-05	0.000383	CcSEcCtD
Morphine—Rash—Sorafenib—kidney cancer	7.96e-05	0.000382	CcSEcCtD
Morphine—Dermatitis—Sorafenib—kidney cancer	7.96e-05	0.000382	CcSEcCtD
Morphine—Back pain—Capecitabine—kidney cancer	7.94e-05	0.000381	CcSEcCtD
Morphine—Breast disorder—Doxorubicin—kidney cancer	7.94e-05	0.000381	CcSEcCtD
Morphine—Skin disorder—Paclitaxel—kidney cancer	7.93e-05	0.000381	CcSEcCtD
Morphine—Headache—Sorafenib—kidney cancer	7.91e-05	0.00038	CcSEcCtD
Morphine—Muscle spasms—Capecitabine—kidney cancer	7.89e-05	0.000379	CcSEcCtD
Morphine—Hyperhidrosis—Paclitaxel—kidney cancer	7.89e-05	0.000379	CcSEcCtD
Morphine—Diarrhoea—Dactinomycin—kidney cancer	7.87e-05	0.000378	CcSEcCtD
Morphine—Nasopharyngitis—Doxorubicin—kidney cancer	7.86e-05	0.000377	CcSEcCtD
Morphine—Anorexia—Paclitaxel—kidney cancer	7.78e-05	0.000374	CcSEcCtD
Morphine—Vision blurred—Capecitabine—kidney cancer	7.74e-05	0.000371	CcSEcCtD
Morphine—Vomiting—Sunitinib—kidney cancer	7.73e-05	0.000371	CcSEcCtD
Morphine—Body temperature increased—Gemcitabine—kidney cancer	7.71e-05	0.00037	CcSEcCtD
Morphine—Tremor—Capecitabine—kidney cancer	7.69e-05	0.000369	CcSEcCtD
Morphine—Rash—Sunitinib—kidney cancer	7.66e-05	0.000368	CcSEcCtD
Morphine—Dermatitis—Sunitinib—kidney cancer	7.66e-05	0.000368	CcSEcCtD
Morphine—Abdominal distension—Doxorubicin—kidney cancer	7.65e-05	0.000367	CcSEcCtD
Morphine—Hypotension—Paclitaxel—kidney cancer	7.63e-05	0.000366	CcSEcCtD
Morphine—Ill-defined disorder—Capecitabine—kidney cancer	7.62e-05	0.000366	CcSEcCtD
Morphine—Headache—Sunitinib—kidney cancer	7.61e-05	0.000365	CcSEcCtD
Morphine—Dysphagia—Doxorubicin—kidney cancer	7.59e-05	0.000365	CcSEcCtD
Morphine—Influenza—Doxorubicin—kidney cancer	7.59e-05	0.000365	CcSEcCtD
Morphine—Anaemia—Capecitabine—kidney cancer	7.59e-05	0.000364	CcSEcCtD
Morphine—Hypersensitivity—Vincristine—kidney cancer	7.57e-05	0.000364	CcSEcCtD
Morphine—Eosinophilia—Doxorubicin—kidney cancer	7.52e-05	0.000361	CcSEcCtD
Morphine—Nausea—Sorafenib—kidney cancer	7.5e-05	0.00036	CcSEcCtD
Morphine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	7.44e-05	0.000357	CcSEcCtD
Morphine—Malaise—Capecitabine—kidney cancer	7.4e-05	0.000355	CcSEcCtD
Morphine—Insomnia—Paclitaxel—kidney cancer	7.38e-05	0.000354	CcSEcCtD
Morphine—Vertigo—Capecitabine—kidney cancer	7.38e-05	0.000354	CcSEcCtD
Morphine—Asthenia—Vincristine—kidney cancer	7.38e-05	0.000354	CcSEcCtD
Morphine—Syncope—Capecitabine—kidney cancer	7.36e-05	0.000353	CcSEcCtD
Morphine—Leukopenia—Capecitabine—kidney cancer	7.35e-05	0.000353	CcSEcCtD
Morphine—Paraesthesia—Paclitaxel—kidney cancer	7.33e-05	0.000352	CcSEcCtD
Morphine—Vomiting—Dactinomycin—kidney cancer	7.32e-05	0.000351	CcSEcCtD
Morphine—Dyspnoea—Paclitaxel—kidney cancer	7.28e-05	0.000349	CcSEcCtD
Morphine—Somnolence—Paclitaxel—kidney cancer	7.26e-05	0.000348	CcSEcCtD
Morphine—Palpitations—Capecitabine—kidney cancer	7.25e-05	0.000348	CcSEcCtD
Morphine—Rash—Dactinomycin—kidney cancer	7.25e-05	0.000348	CcSEcCtD
Morphine—Nausea—Sunitinib—kidney cancer	7.22e-05	0.000347	CcSEcCtD
Morphine—Loss of consciousness—Capecitabine—kidney cancer	7.22e-05	0.000346	CcSEcCtD
Morphine—Dyspepsia—Paclitaxel—kidney cancer	7.19e-05	0.000345	CcSEcCtD
Morphine—Cough—Capecitabine—kidney cancer	7.16e-05	0.000344	CcSEcCtD
Morphine—Dysuria—Doxorubicin—kidney cancer	7.1e-05	0.000341	CcSEcCtD
Morphine—Decreased appetite—Paclitaxel—kidney cancer	7.1e-05	0.000341	CcSEcCtD
Morphine—Hypertension—Capecitabine—kidney cancer	7.09e-05	0.00034	CcSEcCtD
Morphine—Gastrointestinal disorder—Paclitaxel—kidney cancer	7.05e-05	0.000338	CcSEcCtD
Morphine—Fatigue—Paclitaxel—kidney cancer	7.04e-05	0.000338	CcSEcCtD
Morphine—Diarrhoea—Vincristine—kidney cancer	7.03e-05	0.000338	CcSEcCtD
Morphine—Asthenia—Gemcitabine—kidney cancer	7e-05	0.000336	CcSEcCtD
Morphine—Chest pain—Capecitabine—kidney cancer	6.99e-05	0.000336	CcSEcCtD
Morphine—Arthralgia—Capecitabine—kidney cancer	6.99e-05	0.000336	CcSEcCtD
Morphine—Pain—Paclitaxel—kidney cancer	6.98e-05	0.000335	CcSEcCtD
Morphine—Constipation—Paclitaxel—kidney cancer	6.98e-05	0.000335	CcSEcCtD
Morphine—Anxiety—Capecitabine—kidney cancer	6.96e-05	0.000334	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	6.94e-05	0.000333	CcSEcCtD
Morphine—Discomfort—Capecitabine—kidney cancer	6.91e-05	0.000332	CcSEcCtD
Morphine—Pruritus—Gemcitabine—kidney cancer	6.9e-05	0.000331	CcSEcCtD
Morphine—Weight decreased—Doxorubicin—kidney cancer	6.87e-05	0.00033	CcSEcCtD
Morphine—Hyperglycaemia—Doxorubicin—kidney cancer	6.85e-05	0.000329	CcSEcCtD
Morphine—Dry mouth—Capecitabine—kidney cancer	6.84e-05	0.000328	CcSEcCtD
Morphine—Nausea—Dactinomycin—kidney cancer	6.83e-05	0.000328	CcSEcCtD
Morphine—Dizziness—Vincristine—kidney cancer	6.8e-05	0.000326	CcSEcCtD
Morphine—Drowsiness—Doxorubicin—kidney cancer	6.77e-05	0.000325	CcSEcCtD
Morphine—Confusional state—Capecitabine—kidney cancer	6.76e-05	0.000324	CcSEcCtD
Morphine—Feeling abnormal—Paclitaxel—kidney cancer	6.73e-05	0.000323	CcSEcCtD
Morphine—Oedema—Capecitabine—kidney cancer	6.7e-05	0.000322	CcSEcCtD
Morphine—Gastrointestinal pain—Paclitaxel—kidney cancer	6.68e-05	0.00032	CcSEcCtD
Morphine—Diarrhoea—Gemcitabine—kidney cancer	6.67e-05	0.00032	CcSEcCtD
Morphine—Renal failure—Doxorubicin—kidney cancer	6.66e-05	0.00032	CcSEcCtD
Morphine—Infection—Capecitabine—kidney cancer	6.66e-05	0.00032	CcSEcCtD
Morphine—Stomatitis—Doxorubicin—kidney cancer	6.6e-05	0.000317	CcSEcCtD
Morphine—Shock—Capecitabine—kidney cancer	6.59e-05	0.000316	CcSEcCtD
Morphine—Urinary tract infection—Doxorubicin—kidney cancer	6.58e-05	0.000316	CcSEcCtD
Morphine—Conjunctivitis—Doxorubicin—kidney cancer	6.58e-05	0.000316	CcSEcCtD
Morphine—Nervous system disorder—Capecitabine—kidney cancer	6.57e-05	0.000315	CcSEcCtD
Morphine—Thrombocytopenia—Capecitabine—kidney cancer	6.56e-05	0.000315	CcSEcCtD
Morphine—Tachycardia—Capecitabine—kidney cancer	6.54e-05	0.000314	CcSEcCtD
Morphine—Vomiting—Vincristine—kidney cancer	6.54e-05	0.000314	CcSEcCtD
Morphine—Skin disorder—Capecitabine—kidney cancer	6.51e-05	0.000312	CcSEcCtD
Morphine—Sweating—Doxorubicin—kidney cancer	6.49e-05	0.000312	CcSEcCtD
Morphine—Urticaria—Paclitaxel—kidney cancer	6.49e-05	0.000311	CcSEcCtD
Morphine—Rash—Vincristine—kidney cancer	6.48e-05	0.000311	CcSEcCtD
Morphine—Hyperhidrosis—Capecitabine—kidney cancer	6.48e-05	0.000311	CcSEcCtD
Morphine—Dermatitis—Vincristine—kidney cancer	6.48e-05	0.000311	CcSEcCtD
Morphine—Abdominal pain—Paclitaxel—kidney cancer	6.45e-05	0.00031	CcSEcCtD
Morphine—Body temperature increased—Paclitaxel—kidney cancer	6.45e-05	0.00031	CcSEcCtD
Morphine—Headache—Vincristine—kidney cancer	6.44e-05	0.000309	CcSEcCtD
Morphine—Hepatobiliary disease—Doxorubicin—kidney cancer	6.4e-05	0.000307	CcSEcCtD
Morphine—Anorexia—Capecitabine—kidney cancer	6.39e-05	0.000307	CcSEcCtD
Morphine—Hypotension—Capecitabine—kidney cancer	6.26e-05	0.000301	CcSEcCtD
Morphine—Vomiting—Gemcitabine—kidney cancer	6.2e-05	0.000298	CcSEcCtD
Morphine—Bradycardia—Doxorubicin—kidney cancer	6.19e-05	0.000297	CcSEcCtD
Morphine—Rash—Gemcitabine—kidney cancer	6.15e-05	0.000295	CcSEcCtD
Morphine—Dermatitis—Gemcitabine—kidney cancer	6.14e-05	0.000295	CcSEcCtD
Morphine—Headache—Gemcitabine—kidney cancer	6.11e-05	0.000293	CcSEcCtD
Morphine—Nausea—Vincristine—kidney cancer	6.11e-05	0.000293	CcSEcCtD
Morphine—Musculoskeletal discomfort—Capecitabine—kidney cancer	6.1e-05	0.000293	CcSEcCtD
Morphine—Rhinitis—Doxorubicin—kidney cancer	6.09e-05	0.000293	CcSEcCtD
Morphine—Hepatitis—Doxorubicin—kidney cancer	6.08e-05	0.000292	CcSEcCtD
Morphine—Insomnia—Capecitabine—kidney cancer	6.06e-05	0.000291	CcSEcCtD
Morphine—Hypoaesthesia—Doxorubicin—kidney cancer	6.05e-05	0.00029	CcSEcCtD
Morphine—Paraesthesia—Capecitabine—kidney cancer	6.02e-05	0.000289	CcSEcCtD
Morphine—Hypersensitivity—Paclitaxel—kidney cancer	6.02e-05	0.000289	CcSEcCtD
Morphine—Urinary tract disorder—Doxorubicin—kidney cancer	6e-05	0.000288	CcSEcCtD
Morphine—Oedema peripheral—Doxorubicin—kidney cancer	5.99e-05	0.000287	CcSEcCtD
Morphine—Connective tissue disorder—Doxorubicin—kidney cancer	5.97e-05	0.000287	CcSEcCtD
Morphine—Dyspnoea—Capecitabine—kidney cancer	5.97e-05	0.000287	CcSEcCtD
Morphine—Urethral disorder—Doxorubicin—kidney cancer	5.96e-05	0.000286	CcSEcCtD
Morphine—Dyspepsia—Capecitabine—kidney cancer	5.9e-05	0.000283	CcSEcCtD
Morphine—Visual impairment—Doxorubicin—kidney cancer	5.86e-05	0.000281	CcSEcCtD
Morphine—Asthenia—Paclitaxel—kidney cancer	5.86e-05	0.000281	CcSEcCtD
Morphine—Decreased appetite—Capecitabine—kidney cancer	5.82e-05	0.00028	CcSEcCtD
Morphine—Nausea—Gemcitabine—kidney cancer	5.79e-05	0.000278	CcSEcCtD
Morphine—Gastrointestinal disorder—Capecitabine—kidney cancer	5.78e-05	0.000278	CcSEcCtD
Morphine—Fatigue—Capecitabine—kidney cancer	5.78e-05	0.000277	CcSEcCtD
Morphine—Pruritus—Paclitaxel—kidney cancer	5.78e-05	0.000277	CcSEcCtD
Morphine—Constipation—Capecitabine—kidney cancer	5.73e-05	0.000275	CcSEcCtD
Morphine—Pain—Capecitabine—kidney cancer	5.73e-05	0.000275	CcSEcCtD
Morphine—Eye disorder—Doxorubicin—kidney cancer	5.68e-05	0.000273	CcSEcCtD
Morphine—Flushing—Doxorubicin—kidney cancer	5.64e-05	0.000271	CcSEcCtD
Morphine—Diarrhoea—Paclitaxel—kidney cancer	5.59e-05	0.000268	CcSEcCtD
Morphine—Feeling abnormal—Capecitabine—kidney cancer	5.52e-05	0.000265	CcSEcCtD
Morphine—Angiopathy—Doxorubicin—kidney cancer	5.52e-05	0.000265	CcSEcCtD
Morphine—Gastrointestinal pain—Capecitabine—kidney cancer	5.48e-05	0.000263	CcSEcCtD
Morphine—Mediastinal disorder—Doxorubicin—kidney cancer	5.48e-05	0.000263	CcSEcCtD
Morphine—Chills—Doxorubicin—kidney cancer	5.45e-05	0.000262	CcSEcCtD
Morphine—Dizziness—Paclitaxel—kidney cancer	5.4e-05	0.000259	CcSEcCtD
Morphine—Mental disorder—Doxorubicin—kidney cancer	5.33e-05	0.000256	CcSEcCtD
Morphine—Urticaria—Capecitabine—kidney cancer	5.32e-05	0.000256	CcSEcCtD
Morphine—Abdominal pain—Capecitabine—kidney cancer	5.3e-05	0.000254	CcSEcCtD
Morphine—Body temperature increased—Capecitabine—kidney cancer	5.3e-05	0.000254	CcSEcCtD
Morphine—Erythema—Doxorubicin—kidney cancer	5.29e-05	0.000254	CcSEcCtD
Morphine—Malnutrition—Doxorubicin—kidney cancer	5.29e-05	0.000254	CcSEcCtD
Morphine—Flatulence—Doxorubicin—kidney cancer	5.21e-05	0.00025	CcSEcCtD
Morphine—Tension—Doxorubicin—kidney cancer	5.19e-05	0.000249	CcSEcCtD
Morphine—Vomiting—Paclitaxel—kidney cancer	5.19e-05	0.000249	CcSEcCtD
Morphine—Dysgeusia—Doxorubicin—kidney cancer	5.18e-05	0.000249	CcSEcCtD
Morphine—Rash—Paclitaxel—kidney cancer	5.15e-05	0.000247	CcSEcCtD
Morphine—Dermatitis—Paclitaxel—kidney cancer	5.14e-05	0.000247	CcSEcCtD
Morphine—Nervousness—Doxorubicin—kidney cancer	5.14e-05	0.000247	CcSEcCtD
Morphine—Back pain—Doxorubicin—kidney cancer	5.12e-05	0.000246	CcSEcCtD
Morphine—Headache—Paclitaxel—kidney cancer	5.11e-05	0.000246	CcSEcCtD
Morphine—Muscle spasms—Doxorubicin—kidney cancer	5.09e-05	0.000244	CcSEcCtD
Morphine—Vision blurred—Doxorubicin—kidney cancer	4.99e-05	0.000239	CcSEcCtD
Morphine—Hypersensitivity—Capecitabine—kidney cancer	4.94e-05	0.000237	CcSEcCtD
Morphine—Ill-defined disorder—Doxorubicin—kidney cancer	4.91e-05	0.000236	CcSEcCtD
Morphine—Anaemia—Doxorubicin—kidney cancer	4.89e-05	0.000235	CcSEcCtD
Morphine—Agitation—Doxorubicin—kidney cancer	4.86e-05	0.000233	CcSEcCtD
Morphine—Nausea—Paclitaxel—kidney cancer	4.85e-05	0.000233	CcSEcCtD
Morphine—Asthenia—Capecitabine—kidney cancer	4.81e-05	0.000231	CcSEcCtD
Morphine—Malaise—Doxorubicin—kidney cancer	4.77e-05	0.000229	CcSEcCtD
Morphine—Vertigo—Doxorubicin—kidney cancer	4.75e-05	0.000228	CcSEcCtD
Morphine—Syncope—Doxorubicin—kidney cancer	4.75e-05	0.000228	CcSEcCtD
Morphine—Pruritus—Capecitabine—kidney cancer	4.74e-05	0.000228	CcSEcCtD
Morphine—Leukopenia—Doxorubicin—kidney cancer	4.74e-05	0.000227	CcSEcCtD
Morphine—Palpitations—Doxorubicin—kidney cancer	4.68e-05	0.000224	CcSEcCtD
Morphine—Loss of consciousness—Doxorubicin—kidney cancer	4.65e-05	0.000223	CcSEcCtD
Morphine—Cough—Doxorubicin—kidney cancer	4.62e-05	0.000222	CcSEcCtD
Morphine—Convulsion—Doxorubicin—kidney cancer	4.58e-05	0.00022	CcSEcCtD
Morphine—Diarrhoea—Capecitabine—kidney cancer	4.58e-05	0.00022	CcSEcCtD
Morphine—Hypertension—Doxorubicin—kidney cancer	4.57e-05	0.000219	CcSEcCtD
Morphine—Arthralgia—Doxorubicin—kidney cancer	4.51e-05	0.000216	CcSEcCtD
Morphine—Chest pain—Doxorubicin—kidney cancer	4.51e-05	0.000216	CcSEcCtD
Morphine—Anxiety—Doxorubicin—kidney cancer	4.49e-05	0.000216	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	4.47e-05	0.000215	CcSEcCtD
Morphine—Discomfort—Doxorubicin—kidney cancer	4.45e-05	0.000214	CcSEcCtD
Morphine—Dizziness—Capecitabine—kidney cancer	4.43e-05	0.000213	CcSEcCtD
Morphine—Dry mouth—Doxorubicin—kidney cancer	4.41e-05	0.000212	CcSEcCtD
Morphine—Confusional state—Doxorubicin—kidney cancer	4.35e-05	0.000209	CcSEcCtD
Morphine—Oedema—Doxorubicin—kidney cancer	4.32e-05	0.000207	CcSEcCtD
Morphine—Anaphylactic shock—Doxorubicin—kidney cancer	4.32e-05	0.000207	CcSEcCtD
Morphine—Infection—Doxorubicin—kidney cancer	4.29e-05	0.000206	CcSEcCtD
Morphine—Vomiting—Capecitabine—kidney cancer	4.26e-05	0.000205	CcSEcCtD
Morphine—Shock—Doxorubicin—kidney cancer	4.25e-05	0.000204	CcSEcCtD
Morphine—Nervous system disorder—Doxorubicin—kidney cancer	4.24e-05	0.000203	CcSEcCtD
Morphine—Thrombocytopenia—Doxorubicin—kidney cancer	4.23e-05	0.000203	CcSEcCtD
Morphine—Rash—Capecitabine—kidney cancer	4.22e-05	0.000203	CcSEcCtD
Morphine—Dermatitis—Capecitabine—kidney cancer	4.22e-05	0.000203	CcSEcCtD
Morphine—Tachycardia—Doxorubicin—kidney cancer	4.22e-05	0.000202	CcSEcCtD
Morphine—Headache—Capecitabine—kidney cancer	4.2e-05	0.000201	CcSEcCtD
Morphine—Skin disorder—Doxorubicin—kidney cancer	4.19e-05	0.000201	CcSEcCtD
Morphine—Hyperhidrosis—Doxorubicin—kidney cancer	4.18e-05	0.0002	CcSEcCtD
Morphine—Anorexia—Doxorubicin—kidney cancer	4.12e-05	0.000198	CcSEcCtD
Morphine—Hypotension—Doxorubicin—kidney cancer	4.04e-05	0.000194	CcSEcCtD
Morphine—Nausea—Capecitabine—kidney cancer	3.98e-05	0.000191	CcSEcCtD
Morphine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.93e-05	0.000189	CcSEcCtD
Morphine—Insomnia—Doxorubicin—kidney cancer	3.91e-05	0.000188	CcSEcCtD
Morphine—Paraesthesia—Doxorubicin—kidney cancer	3.88e-05	0.000186	CcSEcCtD
Morphine—Dyspnoea—Doxorubicin—kidney cancer	3.85e-05	0.000185	CcSEcCtD
Morphine—Somnolence—Doxorubicin—kidney cancer	3.84e-05	0.000184	CcSEcCtD
Morphine—Dyspepsia—Doxorubicin—kidney cancer	3.8e-05	0.000183	CcSEcCtD
Morphine—Decreased appetite—Doxorubicin—kidney cancer	3.75e-05	0.00018	CcSEcCtD
Morphine—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.73e-05	0.000179	CcSEcCtD
Morphine—Fatigue—Doxorubicin—kidney cancer	3.72e-05	0.000179	CcSEcCtD
Morphine—Constipation—Doxorubicin—kidney cancer	3.69e-05	0.000177	CcSEcCtD
Morphine—Pain—Doxorubicin—kidney cancer	3.69e-05	0.000177	CcSEcCtD
Morphine—Feeling abnormal—Doxorubicin—kidney cancer	3.56e-05	0.000171	CcSEcCtD
Morphine—Gastrointestinal pain—Doxorubicin—kidney cancer	3.53e-05	0.00017	CcSEcCtD
Morphine—Urticaria—Doxorubicin—kidney cancer	3.43e-05	0.000165	CcSEcCtD
Morphine—Abdominal pain—Doxorubicin—kidney cancer	3.41e-05	0.000164	CcSEcCtD
Morphine—Body temperature increased—Doxorubicin—kidney cancer	3.41e-05	0.000164	CcSEcCtD
Morphine—Hypersensitivity—Doxorubicin—kidney cancer	3.18e-05	0.000153	CcSEcCtD
Morphine—Asthenia—Doxorubicin—kidney cancer	3.1e-05	0.000149	CcSEcCtD
Morphine—Pruritus—Doxorubicin—kidney cancer	3.06e-05	0.000147	CcSEcCtD
Morphine—Diarrhoea—Doxorubicin—kidney cancer	2.95e-05	0.000142	CcSEcCtD
Morphine—Dizziness—Doxorubicin—kidney cancer	2.86e-05	0.000137	CcSEcCtD
Morphine—Vomiting—Doxorubicin—kidney cancer	2.75e-05	0.000132	CcSEcCtD
Morphine—Rash—Doxorubicin—kidney cancer	2.72e-05	0.000131	CcSEcCtD
Morphine—Dermatitis—Doxorubicin—kidney cancer	2.72e-05	0.000131	CcSEcCtD
Morphine—Headache—Doxorubicin—kidney cancer	2.71e-05	0.00013	CcSEcCtD
Morphine—Nausea—Doxorubicin—kidney cancer	2.57e-05	0.000123	CcSEcCtD
Morphine—OPRM1—Signaling Pathways—TSC1—kidney cancer	1.34e-05	0.000195	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ANXA1—kidney cancer	1.34e-05	0.000195	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC5A3—kidney cancer	1.34e-05	0.000194	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PGK1—kidney cancer	1.34e-05	0.000194	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PDHB—kidney cancer	1.34e-05	0.000194	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IGF2—kidney cancer	1.33e-05	0.000193	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—POMC—kidney cancer	1.33e-05	0.000193	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CYP1A1—kidney cancer	1.33e-05	0.000193	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDKN2B—kidney cancer	1.33e-05	0.000192	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—POMC—kidney cancer	1.32e-05	0.000191	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.32e-05	0.000191	CbGpPWpGaD
Morphine—ABCB1—Metabolism—LDHB—kidney cancer	1.31e-05	0.00019	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—VEGFA—kidney cancer	1.31e-05	0.00019	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CA9—kidney cancer	1.31e-05	0.000189	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FLT1—kidney cancer	1.3e-05	0.000189	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IGF1R—kidney cancer	1.29e-05	0.000187	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.28e-05	0.000185	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.26e-05	0.000183	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PGK1—kidney cancer	1.26e-05	0.000183	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CCBL1—kidney cancer	1.26e-05	0.000182	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.25e-05	0.000181	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—RAF1—kidney cancer	1.24e-05	0.00018	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GSTP1—kidney cancer	1.24e-05	0.00018	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—LDHB—kidney cancer	1.24e-05	0.000179	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MAPK3—kidney cancer	1.24e-05	0.000179	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—POMC—kidney cancer	1.23e-05	0.000178	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—IL2—kidney cancer	1.23e-05	0.000178	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PIK3CA—kidney cancer	1.22e-05	0.000177	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PAK1—kidney cancer	1.21e-05	0.000175	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—JUNB—kidney cancer	1.21e-05	0.000175	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MYC—kidney cancer	1.2e-05	0.000174	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.18e-05	0.000171	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MAPK1—kidney cancer	1.18e-05	0.000171	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ABCB1—kidney cancer	1.17e-05	0.00017	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IGF2—kidney cancer	1.17e-05	0.000169	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—POMC—kidney cancer	1.17e-05	0.000169	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN2B—kidney cancer	1.16e-05	0.000169	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.15e-05	0.000167	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GSTM1—kidney cancer	1.14e-05	0.000165	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CA9—kidney cancer	1.14e-05	0.000165	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IGF1R—kidney cancer	1.13e-05	0.000164	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.12e-05	0.000163	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—POMC—kidney cancer	1.12e-05	0.000162	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL2—kidney cancer	1.11e-05	0.000161	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—KRAS—kidney cancer	1.11e-05	0.000161	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CRABP1—kidney cancer	1.11e-05	0.000161	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.09e-05	0.000158	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPAT—kidney cancer	1.09e-05	0.000158	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—RAF1—kidney cancer	1.09e-05	0.000158	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CYP1A1—kidney cancer	1.08e-05	0.000157	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—IL2—kidney cancer	1.07e-05	0.000156	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CA9—kidney cancer	1.07e-05	0.000156	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PIK3CA—kidney cancer	1.07e-05	0.000155	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PIK3CA—kidney cancer	1.07e-05	0.000155	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.06e-05	0.000154	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HIF1A—kidney cancer	1.06e-05	0.000154	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TSC2—kidney cancer	1.06e-05	0.000153	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ITPR2—kidney cancer	1.03e-05	0.00015	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PIK3CA—kidney cancer	1.02e-05	0.000148	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KDR—kidney cancer	1.01e-05	0.000147	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—FH—kidney cancer	1.01e-05	0.000147	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—APRT—kidney cancer	1.01e-05	0.000147	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—POMC—kidney cancer	9.92e-06	0.000144	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TP53—kidney cancer	9.89e-06	0.000143	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IGF2—kidney cancer	9.87e-06	0.000143	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN2B—kidney cancer	9.83e-06	0.000142	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL2—kidney cancer	9.76e-06	0.000141	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	9.75e-06	0.000141	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CRABP1—kidney cancer	9.69e-06	0.00014	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IGF1R—kidney cancer	9.54e-06	0.000138	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.53e-06	0.000138	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GPC3—kidney cancer	9.52e-06	0.000138	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	9.44e-06	0.000137	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTT1—kidney cancer	9.42e-06	0.000137	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ACHE—kidney cancer	9.42e-06	0.000137	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KIT—kidney cancer	9.34e-06	0.000135	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—APC—kidney cancer	9.34e-06	0.000135	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTGS2—kidney cancer	9.3e-06	0.000135	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HIF1A—kidney cancer	9.3e-06	0.000135	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TSC2—kidney cancer	9.27e-06	0.000134	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CA2—kidney cancer	9.26e-06	0.000134	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—RAF1—kidney cancer	9.2e-06	0.000133	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CRABP1—kidney cancer	9.13e-06	0.000132	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—IL2—kidney cancer	9.08e-06	0.000132	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALAD—kidney cancer	9.02e-06	0.000131	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ITPR2—kidney cancer	9e-06	0.00013	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—MAPK3—kidney cancer	8.95e-06	0.00013	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SCARB1—kidney cancer	8.92e-06	0.000129	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—POMC—kidney cancer	8.89e-06	0.000129	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KDR—kidney cancer	8.89e-06	0.000129	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS1—kidney cancer	8.83e-06	0.000128	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.81e-06	0.000128	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—BRAF—kidney cancer	8.78e-06	0.000127	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PSMD7—kidney cancer	8.66e-06	0.000126	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.61e-06	0.000125	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—MAPK1—kidney cancer	8.51e-06	0.000123	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ITPR2—kidney cancer	8.48e-06	0.000123	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PGK1—kidney cancer	8.25e-06	0.00012	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC5A3—kidney cancer	8.25e-06	0.00012	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL2—kidney cancer	8.25e-06	0.000119	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTT1—kidney cancer	8.21e-06	0.000119	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ACHE—kidney cancer	8.21e-06	0.000119	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—BCHE—kidney cancer	8.21e-06	0.000119	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KIT—kidney cancer	8.19e-06	0.000119	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—APC—kidney cancer	8.19e-06	0.000119	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—PIK3CA—kidney cancer	8.13e-06	0.000118	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTEN—kidney cancer	8.11e-06	0.000118	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SLC5A5—kidney cancer	8.11e-06	0.000118	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LDHB—kidney cancer	8.09e-06	0.000117	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—POMC—kidney cancer	8.06e-06	0.000117	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—KRAS—kidney cancer	8.04e-06	0.000116	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTGS2—kidney cancer	7.91e-06	0.000115	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HIF1A—kidney cancer	7.86e-06	0.000114	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—MAPK3—kidney cancer	7.84e-06	0.000114	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TSC2—kidney cancer	7.84e-06	0.000114	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SLC2A1—kidney cancer	7.83e-06	0.000114	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—POMC—kidney cancer	7.8e-06	0.000113	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SCARB1—kidney cancer	7.77e-06	0.000113	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ACHE—kidney cancer	7.74e-06	0.000112	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTT1—kidney cancer	7.74e-06	0.000112	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—BRAF—kidney cancer	7.7e-06	0.000112	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS1—kidney cancer	7.69e-06	0.000111	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.6e-06	0.00011	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PSMD7—kidney cancer	7.55e-06	0.000109	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KDR—kidney cancer	7.51e-06	0.000109	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—MAPK1—kidney cancer	7.46e-06	0.000108	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PIK3CA—kidney cancer	7.39e-06	0.000107	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—RAF1—kidney cancer	7.33e-06	0.000106	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SCARB1—kidney cancer	7.32e-06	0.000106	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—RELA—kidney cancer	7.3e-06	0.000106	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ERBB2—kidney cancer	7.25e-06	0.000105	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS1—kidney cancer	7.25e-06	0.000105	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MTOR—kidney cancer	7.16e-06	0.000104	CbGpPWpGaD
Morphine—ABCB1—Metabolism—BCHE—kidney cancer	7.15e-06	0.000104	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—PIK3CA—kidney cancer	7.13e-06	0.000103	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PSMD7—kidney cancer	7.11e-06	0.000103	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC5A5—kidney cancer	7.07e-06	0.000102	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—KRAS—kidney cancer	7.05e-06	0.000102	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CA9—kidney cancer	7.02e-06	0.000102	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—APC—kidney cancer	6.92e-06	0.0001	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KIT—kidney cancer	6.92e-06	0.0001	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTEN—kidney cancer	6.9e-06	0.0001	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC2A1—kidney cancer	6.82e-06	9.89e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—BCHE—kidney cancer	6.74e-06	9.77e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDKN1B—kidney cancer	6.72e-06	9.73e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC5A5—kidney cancer	6.66e-06	9.65e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—MAPK3—kidney cancer	6.63e-06	9.61e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.63e-06	9.6e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—POMC—kidney cancer	6.59e-06	9.55e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL2—kidney cancer	6.57e-06	9.52e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTP1—kidney cancer	6.53e-06	9.47e-05	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.51e-06	9.43e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—BRAF—kidney cancer	6.51e-06	9.43e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PIK3CA—kidney cancer	6.48e-06	9.38e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC2A1—kidney cancer	6.43e-06	9.32e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RAF1—kidney cancer	6.43e-06	9.31e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—kidney cancer	6.43e-06	9.31e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCND1—kidney cancer	6.41e-06	9.28e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RELA—kidney cancer	6.4e-06	9.27e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—JUN—kidney cancer	6.39e-06	9.27e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ERBB2—kidney cancer	6.36e-06	9.22e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CTNNB1—kidney cancer	6.35e-06	9.19e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—MAPK1—kidney cancer	6.31e-06	9.14e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MTOR—kidney cancer	6.28e-06	9.09e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTEN—kidney cancer	6.18e-06	8.96e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ABCB1—kidney cancer	6.18e-06	8.96e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CA—kidney cancer	6.03e-06	8.73e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTM1—kidney cancer	6e-06	8.7e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CRABP1—kidney cancer	5.97e-06	8.65e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—KRAS—kidney cancer	5.96e-06	8.63e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN1B—kidney cancer	5.89e-06	8.53e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL2—kidney cancer	5.76e-06	8.35e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CA—kidney cancer	5.72e-06	8.29e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTP1—kidney cancer	5.69e-06	8.25e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.69e-06	8.25e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCND1—kidney cancer	5.62e-06	8.14e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—JUN—kidney cancer	5.61e-06	8.12e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTEN—kidney cancer	5.61e-06	8.12e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—kidney cancer	5.59e-06	8.09e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CTNNB1—kidney cancer	5.56e-06	8.06e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ITPR2—kidney cancer	5.55e-06	8.04e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CA—kidney cancer	5.47e-06	7.93e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RAF1—kidney cancer	5.43e-06	7.87e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTEN—kidney cancer	5.42e-06	7.86e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RELA—kidney cancer	5.41e-06	7.84e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ERBB2—kidney cancer	5.37e-06	7.79e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTP1—kidney cancer	5.36e-06	7.77e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MTOR—kidney cancer	5.3e-06	7.69e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAPK3—kidney cancer	5.28e-06	7.66e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTM1—kidney cancer	5.23e-06	7.58e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MYC—kidney cancer	5.14e-06	7.45e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ABCB1—kidney cancer	5.08e-06	7.36e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTT1—kidney cancer	5.06e-06	7.33e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ACHE—kidney cancer	5.06e-06	7.33e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAPK1—kidney cancer	5.03e-06	7.29e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN1B—kidney cancer	4.98e-06	7.21e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP1A1—kidney cancer	4.96e-06	7.18e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTM1—kidney cancer	4.93e-06	7.14e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—kidney cancer	4.9e-06	7.1e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL2—kidney cancer	4.87e-06	7.06e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CA—kidney cancer	4.87e-06	7.05e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SCARB1—kidney cancer	4.79e-06	6.94e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KRAS—kidney cancer	4.75e-06	6.88e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCND1—kidney cancer	4.75e-06	6.88e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS1—kidney cancer	4.74e-06	6.87e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—JUN—kidney cancer	4.74e-06	6.87e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CTNNB1—kidney cancer	4.7e-06	6.81e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.68e-06	6.78e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP1A1—kidney cancer	4.67e-06	6.77e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PSMD7—kidney cancer	4.65e-06	6.74e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAPK3—kidney cancer	4.63e-06	6.71e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTEN—kidney cancer	4.58e-06	6.64e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MYC—kidney cancer	4.51e-06	6.53e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAPK1—kidney cancer	4.41e-06	6.39e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—BCHE—kidney cancer	4.41e-06	6.39e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CA—kidney cancer	4.36e-06	6.32e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.35e-06	6.31e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—POMC—kidney cancer	4.24e-06	6.15e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—kidney cancer	4.22e-06	6.12e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.2e-06	6.09e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KRAS—kidney cancer	4.16e-06	6.03e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—kidney cancer	4.14e-06	6e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CA—kidney cancer	3.95e-06	5.73e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK3—kidney cancer	3.92e-06	5.67e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CA—kidney cancer	3.83e-06	5.54e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MYC—kidney cancer	3.81e-06	5.52e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK1—kidney cancer	3.73e-06	5.4e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—kidney cancer	3.7e-06	5.36e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—POMC—kidney cancer	3.7e-06	5.36e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KRAS—kidney cancer	3.52e-06	5.1e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTP1—kidney cancer	3.51e-06	5.08e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—POMC—kidney cancer	3.48e-06	5.05e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—kidney cancer	3.38e-06	4.9e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ABCB1—kidney cancer	3.32e-06	4.81e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CA—kidney cancer	3.23e-06	4.69e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTM1—kidney cancer	3.22e-06	4.67e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—kidney cancer	3.13e-06	4.53e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.05e-06	4.43e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTEN—kidney cancer	2.95e-06	4.28e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—kidney cancer	2.95e-06	4.27e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—kidney cancer	2.78e-06	4.03e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTEN—kidney cancer	2.57e-06	3.73e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTEN—kidney cancer	2.42e-06	3.51e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—POMC—kidney cancer	2.28e-06	3.3e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.08e-06	3.02e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.82e-06	2.63e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CA—kidney cancer	1.81e-06	2.63e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.71e-06	2.48e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTEN—kidney cancer	1.58e-06	2.3e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.12e-06	1.62e-05	CbGpPWpGaD
